Drugs / Yangzhengxiaoji capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01949818 | Sep 2012 → Sep 2016 | diffuse large B-cell lymphoma | Mingzhi Zhang | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yangzhengxiaoji capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01949818 ↗ |
| Route | Oral | “Yangzhengxiaoji capsule ,1.56g,Tid,p.o,d7-21” NCT01949818 ↗ |